Previous 10 | Next 10 |
Ocugen’s intranasal candidate is one of the world’s most advanced intranasal COVID-19 vaccines Intranasal vaccine is designed to curb virus transmission and confer protective immunity MALVERN, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen) (N...
Malvern, Pennsylvania-based biotech Ocugen, Inc. ( NASDAQ: OCGN ) announced Wednesday that the journal Frontiers in Immunology published a review on the COVID-19 vaccine the company is developing in partnership with India-based Bharat Biotech. Highlights of the review ...
Data include the persistence of immune responses and protection against variants of concern, especially Delta and Omicron Ocugen has North American commercialization rights for BBV152, commercialized as COVAXIN™ MALVERN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) --...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Washington’s fiscal and monetary stimulus has wound down, meme stocks and cryptocurrencies are tumbling tremendously. Consequently, any names connected to either phenomenon are good growth stocks to sell. Retail...
MALVERN, Pa., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company&...
MALVERN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, announced that Dr. Shankar Musunu...
Although it hasn't been the most popular coronavirus stock, Ocugen (NASDAQ: OCGN) clearly found some new fans on Thursday. The company's shares bumped almost 2% higher on news of some fresh faces in the biotech's C-suite. In a one-two punch, Ocugen has appointed a new chief medi...
MALVERN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the appointment of Robert J. Hopkins, MD, MPH &am...
Shares of clinical-stage biotech Ocugen (NASDAQ: OCGN) are on fire today. Specifically, the biopharma's stock was up by a healthy 13.7%, on higher-than-normal volume, as of 2:46 p.m. ET Wednesday afternoon. What's sparking this double-digit spike in Ocugen's share price? Mizuh...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Oil and Gas Photographer / Shutterstock.com Indonesia Energy (NYSEMKT: INDO ) stock is rising higher on Tuesday alongside the increasing price of natural gas . And it’s not a small increase, ei...
News, Short Squeeze, Breakout and More Instantly...
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and va...
2024-07-11 08:45:00 ET It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF , is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have...